Mantis Biotech

Mantis is an early-stage B2B software infrastructure startup developing advanced digital twins of humans by combining large language models with high-fidelity physics simulations. The company primarily focuses on converting rare and inaccessible human behavioral data into actionable predictive models for complex enterprise software applications. By integrating advanced artificial intelligence with physical modeling, the platform allows organizations to simulate human interactions and responses within highly controlled digital environments. Operating with a dedicated core team of three employees, the venture is backed by lead investor Y Combinator and was selected to participate in the prominent Silicon Valley accelerator's Winter 2026 batch. Formerly known as Mantis Biotechnology, the active organization operates within the broader technology sector to provide specialized simulation capabilities that reduce corporate reliance on traditional, time-consuming data collection methods. Mantis was officially founded in 2025.